The two companies with the steepest increases market blockbuster medications that saw deep price cuts in 2026.

Bacteria fend off invading viruses with molecular scissors that slice up viral DNA—a system called CRISPR that's become ...

The big pharma companies involved in Trump’s new drug pricing program spent over $130 million on lobbying in 2025.

Merck & Co. scientists use a suite of enzymes to manufacture the cholesterol-lowering drug candidate enlicitide ...

Advancing small molecules from R&D to GMP requires coordinated strategies to support phase I clinical manufacturing.

Interim clinical data from GFORCE-1 trial of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in subjects with elevated CVD risk; readout of expanded GFORCE-1 trial in subjects with ele ...

Global warming and climate change has resulted in soil degradation, and rising agricultural demands that necessitates climate ...

Ming, Professor of the Department of Chemical and Biological Engineering (CBE) at The Hong Kong University of Science and ...

A WA biotech duo, ProGenis and Syngenis Laboratories, is developing RNA-based therapies at the next frontier in diabetes ...

Bayer and Perfuse Therapeutics Inc. today announced an agreement under which Bayer will fully acquire Perfuse Therapeutics, a biopharmaceutical company pioneering transformational research into the ...

From studying microRNAs in embryonic stem cells to exploring exosomes in anti-tumor immunity, Blelloch illustrates how ...

In 2022, obesity contributed just 1% of the projected value of pharma industry pipeline, as calculated by Deloitte. Now, its ...